San-Miguel, J., Usmani, S. Z., Mateos, M.-V., van de Donk, N. W., Kaufman, J. L., Moreau, P., Oriol, A., Plesner, T., Benboubker, L., Liu, K., Hellemans, P., Masterson, T., Clemens, P. L., Luo, M., Farnsworth, A., Nahi, H. and Chari, A. (2021) “Subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma: Part 2 of the open-label, multicenter, dose-escalation phase 1b study (PAVO)”, Haematologica. Pavia, Italy, 106(6), pp. 1725-1732. doi: 10.3324/haematol.2019.243790.